PortViewPortView
Stryker logo

Stryker (SYK) Stock Analysis

NYSEHealth CareMedical Devices

$318.53+0.36%
1-year price historyRange $282.58 – $394.34
52-week range$318.53
$281.00$396.86

What Stryker does

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Key metrics

Market cap
$122.11B
P/E (TTM)
23.79
EPS (TTM)
$13.39
Beta
0.77
Dividend yield
1.09%
Revenue / share
$67.37
50-day avg
$329.24
200-day avg
$339.31
52-week high
$396.86
52-week low
$281.00
CEO
Kevin A. Lobo

ETFs linked to SYK

Broad-market and Health Care sector ETFs an investor holding Stryker is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SYK fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SYK in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Stryker?
Stryker trades under the ticker SYK on NYSE.
Which exchange is SYK listed on?
SYK is listed on NYSE.
What sector does Stryker operate in?
Stryker is classified in the Health Care sector (Medical Devices industry).
How can PortView help analyze SYK in a portfolio?
PortView shows SYK's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.